EcoDrugPlus

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSPTIG00000006577
Gene Symbol: CCR1
2 Cross references
299 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSPTIG00000009992
Gene Symbol: CCR4
2 Cross references
254 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSPTIG00000014237
Gene Symbol: CCR9
2 Cross references
262 Possible Orthologues:

C-X-C Motif Chemokine Ligand 8

Ensembl ID : ENSPTIG00000019023
Gene Symbol: CXCL8
2 Cross references
183 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSPTIG00000021235
Gene Symbol: CXCR4
2 Cross references
283 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSPTIG00000017030
Gene Symbol: CFTR
2 Cross references
216 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSPTIG00000015548
Gene Symbol: DNMT1
2 Cross references
206 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSPTIG00000017003
Gene Symbol: TOP1
1 Cross references
270 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSPTIG00000017914
Gene Symbol: TOP2A
2 Cross references
209 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSPTIG00000006585
Gene Symbol: TOP2B
2 Cross references
208 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSPTIG00000017577
Gene Symbol: EML4
1 Cross references
209 Possible Orthologues:

Eph Receptor A2

Ensembl ID : ENSPTIG00000000837
Gene Symbol: EPHA2
2 Cross references
124 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).